(firstQuint)Comparison of Two Triple Regimens for Treatment and Retreatment of Chronic Hepatitis C Infection.

 The objective of the study is to compare the effect of adding 2 oral hepatitis C virus (HCV) protease inhibitors, telaprevir versus boceprevir, as part of current standard treatment regimen with (pegylated-interferon-alpha + ribavirin) for HCV Genotype-1 infection.

 Data will be obtained from medical records of consenting patients.

.

 Comparison of Two Triple Regimens for Treatment and Retreatment of Chronic Hepatitis C Infection@highlight

The purpose of this observational study is to compare two approved treatment regimen(s) containing boceprevir and telaprevir, as part of standard of care for the treatment of hepatitis C.

